Company
Benitec Biopharma Inc. (BNTC)
Standardized SEC financial data for Benitec Biopharma Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001808898 · NASDAQ · Pharmaceutical Preparations.
Revenue growth (YoY)
-100.0%
Return on equity
-39.0%
Free cash flow
-$23.6M
Current ratio
54.67×
EPS (diluted)
$-1.05
Ratios for fiscal year 2024, standardized from SEC filings.
Income statement
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $102K | $59K | $73K | $75K | $0 | — |
| R&D expense |
Balance sheet
| USD | FY2023 | FY2024 | FY2024 | FY2024 | FY2025 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | — | — | $50.9M | — | — | $97.9M |
| Total current assets |
Cash flow
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$7.5M | -$12.8M | -$15.9M | -$18.0M | -$19.4M | -$23.6M |
| Capital expenditures |
Get BNTC data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/BNTC/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/BNTC/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"